The Latest Breaking News from FDA

A federal appeals court partly granted the Biden administration’s request to put on hold a Texas court ruling overturning FDA approval of the abortion pill, but allowed restrictions that were lifted since 2016 to be reinstated.

Plus: New developments in the Texas abortion drug ruling, fallout from the Riley Gaines event at SFSU, and more...

A federal appeals court allowed the nation’s most-used medication abortion drug to remain on the market after Saturday.

People are seeking the advance provision of medication before Friday’s deadline, when the drug may become unavailable

An appeals court ruling prevents an outright ban on mifepristone, but the conservative panel has effectively made the drug harder for millions of Americans to obtain

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

Mark my words: Contraception is the next front in the war on women. And we can't say we haven't been warned.

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail.

A federal appeals court has preserved access to an abortion drug for now but under tighter rules that would allow the drug only to be dispensed up to seven weeks, not 10, and not by mail